A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT01897389
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2014-01-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 70
- Registration Number
- NCT01887535
An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment
Completed
- Conditions
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 119924
- Registration Number
- NCT01881438
A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia
- First Posted Date
- 2013-06-18
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 461
- Registration Number
- NCT01880294
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2019-05-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 5081
- Registration Number
- NCT01877915
A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 16
- Registration Number
- NCT01873001
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 211
- Registration Number
- NCT01867762
A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT01866033
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 141
- Registration Number
- NCT01866007
A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 28
- Registration Number
- NCT01863784
© Copyright 2024. All Rights Reserved by MedPath